GS

Girish Shreedhar Kulkarni

Active Director Designated Partner DIN 09245573
DIN 09245573 First appointment Jul 2021 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Girish Shreedhar Kulkarni

Data last updated:

Girish Shreedhar Kulkarni is a Designated Partner at Cedar Biosciences Llp (since 2021). The company operates in Research & Development.

DIN 09245573
Primary Designation Designated Partner
Industry Research & Development
First Appointment 19 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jul 20212021Active

Board colleagues of Girish Shreedhar Kulkarni

NameDINCompanyDesignation
Mohan Eknath Tulapurkar09245574Cedar Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Cedar Biosciences Llp
Premium access

Shareholding and investment profile for Girish Shreedhar Kulkarni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girish Shreedhar Kulkarni

Girish Shreedhar Kulkarni currently holds 1 directorship: Cedar Biosciences Llp (Designated Partner, since 19 Jul 2021).

Girish Shreedhar Kulkarni was first appointed on 19 Jul 2021 as Designated Partner at Cedar Biosciences Llp.

The current boards of Girish Shreedhar Kulkarni's companies include Mohan Eknath Tulapurkar (Cedar Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available